These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 16416007)
21. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation. Tang H; Goldberg E J Androl; 2009; 30(2):157-67. PubMed ID: 18930904 [TBL] [Abstract][Full Text] [Related]
22. Identification of regulatory regions of the putative tumor suppressor gene DMBT1. Lualdi E; Chiariello E; Finocchiaro G Biochem Biophys Res Commun; 2000 Apr; 270(2):673-5. PubMed ID: 10753682 [TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity and microsatellite instability on chromosome arm 10q in neuroblastoma. Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío IJ; Castresana JS Cancer Genet Cytogenet; 2007 Apr; 174(1):1-8. PubMed ID: 17350460 [TBL] [Abstract][Full Text] [Related]
24. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer. Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278 [TBL] [Abstract][Full Text] [Related]
25. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines. Kim YI; Shin MK; Lee JW; Chung JH; Lee MH Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457 [TBL] [Abstract][Full Text] [Related]
26. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591 [TBL] [Abstract][Full Text] [Related]
27. [Relationship between RAR-beta gene expression defect and its methylation]. Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338 [TBL] [Abstract][Full Text] [Related]
28. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer. Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A Anticancer Res; 2006; 26(6B):4267-70. PubMed ID: 17201143 [TBL] [Abstract][Full Text] [Related]
29. Methylation of the ASC gene promoter is associated with aggressive prostate cancer. Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203 [TBL] [Abstract][Full Text] [Related]
30. Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers. Cai LY; Abe M; Izumi S; Imura M; Yasugi T; Ushijima T Life Sci; 2007 Mar; 80(16):1458-65. PubMed ID: 17303177 [TBL] [Abstract][Full Text] [Related]
31. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status. Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569 [TBL] [Abstract][Full Text] [Related]
32. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas. Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507 [TBL] [Abstract][Full Text] [Related]
33. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. Kim M; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Norman JC; Caswell PT; Kang GH; Kim SY; Yoo HS; Kim YS Carcinogenesis; 2008 Mar; 29(3):629-37. PubMed ID: 18283041 [TBL] [Abstract][Full Text] [Related]
34. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529 [TBL] [Abstract][Full Text] [Related]
35. Silencing of bidirectional promoters by DNA methylation in tumorigenesis. Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430 [TBL] [Abstract][Full Text] [Related]
36. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Mollenhauer J; Wiemann S; Scheurlen W; Korn B; Hayashi Y; Wilgenbus KK; von Deimling A; Poustka A Nat Genet; 1997 Sep; 17(1):32-9. PubMed ID: 9288095 [TBL] [Abstract][Full Text] [Related]
37. Lack of DMBT1 expression in oesophageal, gastric and colon cancers. Mori M; Shiraishi T; Tanaka S; Yamagata M; Mafune K; Tanaka Y; Ueo H; Barnard GF; Sugimachi K Br J Cancer; 1999 Jan; 79(2):211-3. PubMed ID: 9888459 [TBL] [Abstract][Full Text] [Related]
38. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Mollenhauer J; Herbertz S; Holmskov U; Tolnay M; Krebs I; Merlo A; Schrøder HD; Maier D; Breitling F; Wiemann S; Gröne HJ; Poustka A Cancer Res; 2000 Mar; 60(6):1704-10. PubMed ID: 10749143 [TBL] [Abstract][Full Text] [Related]
39. DNA methylation in neuroblastic tumors. Banelli B; Di Vinci A; Gelvi I; Casciano I; Allemanni G; Bonassi S; Romani M Cancer Lett; 2005 Oct; 228(1-2):37-41. PubMed ID: 15923079 [TBL] [Abstract][Full Text] [Related]
40. Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas. Mollenhauer J; Helmke B; Müller H; Kollender G; Lyer S; Diedrichs L; Holmskov U; Ligtenberg T; Herbertz S; Krebs I; Wiemann S; Madsen J; Bikker F; Schmitt L; Otto HF; Poustka A Genes Chromosomes Cancer; 2002 Oct; 35(2):164-9. PubMed ID: 12203780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]